News

As a diversified company with a robust generics business, Amneal is now the 5th largest generics business in the United States, with a growing, high-margin specialty franchise. Shares

The US Food and Drug Administration (FDA), which accepted the company’s supplemental Biologics License Application (sBLA), gave the designation for the combination to be used as first-line treatment

The oral formulation of cobitolimod is a potential follow-on product to the topical formulation, which is currently being investigated in the CONDUCT study – a phase IIb dose

In its inaugural year, the Pathways program will support research projects focused on helping those living with substance use disorders (SUD), including those relating to the use of

The approval is for patients in whom the tumor cannot be removed by surgery or has spread to other parts of the body, and has the abnormal gene,

Horizon secured an unsolicited and highly conditional proposal from Abcam. Abcam has offered £1.81 per Horizon share, which represents a premium of only 25.7% to its share on 1

monARC's multi-disciplinary team of drug developers and technology experts have built disease-specific patient network applications and online tools that prequalify and engage patients during protocol development prior to

Casma is pioneering novel strategies to boost autophagy to arrest or reverse the progression of rare genetic diseases and broader pathologies, including neurodegeneration. Autophagy is the natural process

The deal now includes shared antigen mRNA cancer vaccines including mRNA-5671, Moderna’s mRNA KRAS cancer vaccine. Merck and Moderna will now jointly advance mRNA-5671 in human studies, and